guest ::
| Home > Publications database > The 'unnatural' history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance. > print |
| Home > Publications database > The 'unnatural' history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance. > print |
| 001 | 157159 | ||
| 005 | 20240229133506.0 | ||
| 024 | 7 | _ | |a 10.1002/ijc.33224 |2 doi |
| 024 | 7 | _ | |a pmid:32683684 |2 pmid |
| 024 | 7 | _ | |a 0020-7136 |2 ISSN |
| 024 | 7 | _ | |a 1097-0215 |2 ISSN |
| 024 | 7 | _ | |a altmetric:86118246 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-01439 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Ahadova, Aysel |0 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a The 'unnatural' history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance. |
| 260 | _ | _ | |a Bognor Regis |c 2021 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1609159405_26911 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:F210#LA:F210#2021 Feb 15;148(4):800-811 |
| 520 | _ | _ | |a Individuals with Lynch syndrome (LS), one of the most common inherited cancer syndromes, are at increased risk of developing malignancies, in particular colorectal cancer (CRC). Regular colonoscopy with polypectomy is recommended to reduce CRC risk in LS individuals. However, recent independent studies demonstrated that a substantial proportion of LS individuals develop CRC despite regular colonoscopy. The reasons for this surprising observation confirmed by large prospective studies are a matter of debate. In this review, we collect existing evidence from clinical, epidemiological and molecular studies and interpret them with regard to the origins and progression of LS-associated CRC. Alongside with hypotheses addressing colonoscopy quality and pace of progression from adenoma to cancer, we discuss the role of alternative precursors and of immune system in LS-associated CRC. We also identify gaps in current knowledge and make suggestions for future studies aiming at improved CRC prevention for LS individuals. This article is protected by copyright. All rights reserved. |
| 536 | _ | _ | |a 316 - Infektionen, Entzündung und Krebs (POF4-316) |0 G:(DE-HGF)POF4-316 |c POF4-316 |x 0 |f POF IV |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Seppälä, Toni T |b 1 |
| 700 | 1 | _ | |a Engel, Christoph |0 0000-0002-7247-282X |b 2 |
| 700 | 1 | _ | |a Gallon, Richard |b 3 |
| 700 | 1 | _ | |a Burn, John |b 4 |
| 700 | 1 | _ | |a Holinski-Feder, Elke |b 5 |
| 700 | 1 | _ | |a Steinke-Lange, Verena |0 0000-0001-8491-3234 |b 6 |
| 700 | 1 | _ | |a Möslein, Gabriela |b 7 |
| 700 | 1 | _ | |a Nielsen, Maartje |b 8 |
| 700 | 1 | _ | |a Ten Broeke, Sanne |b 9 |
| 700 | 1 | _ | |a Laghi, Luigi |b 10 |
| 700 | 1 | _ | |a Dominguez-Valentin, Mev |0 0000-0001-7856-0057 |b 11 |
| 700 | 1 | _ | |a Capella, Gabriel |b 12 |
| 700 | 1 | _ | |a Macrae, Finlay |b 13 |
| 700 | 1 | _ | |a Scott, Rodney |b 14 |
| 700 | 1 | _ | |a Hüneburg, Robert |b 15 |
| 700 | 1 | _ | |a Nattermann, Jacob |b 16 |
| 700 | 1 | _ | |a Hoffmeister, Michael |0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f |b 17 |u dkfz |
| 700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 18 |u dkfz |
| 700 | 1 | _ | |a Bläker, Hendrik |b 19 |
| 700 | 1 | _ | |a von Knebel Doeberitz, Magnus |0 P:(DE-He78)11747cd1dc061b9333c0e3a3ff31bf2f |b 20 |u dkfz |
| 700 | 1 | _ | |a Sampson, Julian R |b 21 |
| 700 | 1 | _ | |a Vasen, Hans |b 22 |
| 700 | 1 | _ | |a Mecklin, Jukka-Pekka |b 23 |
| 700 | 1 | _ | |a Møller, Pål |b 24 |
| 700 | 1 | _ | |a Kloor, Matthias |0 P:(DE-He78)028ee60cca729028708496826f077b58 |b 25 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1002/ijc.33224 |g p. ijc.33224 |0 PERI:(DE-600)1474822-8 |n 4 |p 800-811 |t International journal of cancer |v 148 |y 2021 |x 1097-0215 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:157159 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)11747cd1dc061b9333c0e3a3ff31bf2f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)028ee60cca729028708496826f077b58 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-316 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Infections and cancer |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-316 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Infektionen, Entzündung und Krebs |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-02-26 |w ger |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2020-02-26 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-02-26 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-02-26 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-02-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-02-26 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2018 |d 2020-02-26 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2020-02-26 |
| 920 | 2 | _ | |0 I:(DE-He78)F210-20160331 |k F210 |l Angewandte Tumorbiologie |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)F210-20160331 |k F210 |l Angewandte Tumorbiologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)F210-20160331 |k F210 |l Angewandte Tumorbiologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)C120-20160331 |k C120 |l Präventive Onkologie |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)F210-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C070-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C120-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|